Stay updated on Roxadustat in End-Stage Renal Disease Clinical Trial
Sign up to get notified when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.

Latest updates to the Roxadustat in End-Stage Renal Disease Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublication section wording updated to say: 'These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study,' and the revision version updated to v3.3.2. The prior wording indicating PubMed sources and automatic creation by ClinicalTrials.gov (NCT Number) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the generic funding/operating-status notice that warned users information may not be up to date; this does not affect the study data or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedBoth screenshots show the same Study Details page for NCT01147666 with no substantive changes to core content or data. Any differences appear to be cosmetic or layout-related.SummaryDifference0.2%

- Check71 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference2%

- Check79 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.2%

- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. Overall, changes are minor and do not affect pricing, stock, or time-based information.SummaryDifference0.1%

Stay in the know with updates to Roxadustat in End-Stage Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.